Home › Major Depressive Disorder › Arkansas › Little Rock
Pag-aaral pangklinika para sa Major Depressive Disorder sa Little Rock, AR
14 pag-aaral para sa Major Depressive Disorder ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Little Rock (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Nagre-recruitPhase 3
- Preferred Research Partners, Inc., Little Rock
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Nagre-recruitPhase 3
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · 15 mi ang layo
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Nagre-recruitPhase 3
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · 15 mi ang layo
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Nagre-recruitPhase 3
- Vanda Investigational Site, Little Rock
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Nagre-recruitPhase 4
- Neurocrine Clinical Site, Bryant · 15 mi ang layo
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
Nagre-recruitPhase 3
- SanRo Clinical Research Group, Bryant · 15 mi ang layo
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
Nagre-recruitPhase 2
- Draig Clinical Site, Little Rock
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Nagre-recruitPhase 2
- Draig Clinical Site, Little Rock
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Nagre-recruitPhase 3
- Neurocrine Clinical Site, Bryant · 15 mi ang layo
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Nagre-recruitPhase 3
- Woodland International Research Group, Little Rock
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Nagre-recruitPhase 3
- Neurocrine Clinical Site, Little Rock
- Neurocrine Clinical Site, Bryant · 15 mi ang layo
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
Nagre-recruitPhase 2
- Preferred Research Partners /ID# 279206, Little Rock
- Woodland International Research Group /ID# 277605, Little Rock
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
Nagre-recruitPhase 2
- Pillar Clinical Research, LLC, Little Rock
- Preferred Research Partners, Inc., Little Rock
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Nagre-recruitPhase 3
- Neurocrine Clinical Site, Little Rock
Pag-aaral para sa Major Depressive Disorder sa ibang lungsod
- New York City, NY36 pag-aaral
- Boston, MA31 pag-aaral
- Atlanta, GA25 pag-aaral
- Philadelphia, PA23 pag-aaral
- Orlando, FL19 pag-aaral
- Miami, FL18 pag-aaral
- Chicago, IL17 pag-aaral
- Tampa, FL17 pag-aaral
- San Diego, CA16 pag-aaral
- Houston, TX16 pag-aaral
- Austin, TX13 pag-aaral
- Las Vegas, NV13 pag-aaral
Iba pang pag-aaral sa Little Rock
- Schizophrenia19 pag-aaral
- Kanser (lahat ng uri)14 pag-aaral
- Acute Myeloid Leukemia13 pag-aaral
- Non-Small Cell Lung Cancer13 pag-aaral
- Obesity11 pag-aaral
- Kanser ng Endometrium10 pag-aaral
- Depression10 pag-aaral
- Type 2 Diabetes10 pag-aaral
- Kanser sa Baga9 pag-aaral
- Sakit sa Puso at Ugat ng Dugo9 pag-aaral
- Kanser sa Pantog9 pag-aaral
- Pagkabigo ng Puso9 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.